Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Effects of DAC treatment
PubMed Full text in PMC Similar studies Analyze with GEO2R
Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Probe Name version)
Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Feature Number version)
Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482)
Illumina HumanMethylation27 BeadChip (HumanMethylation27_270596_v.1.2)
KG1A 10nM DAC day14 [mRNA profiling]
KG1A 10nM DAC day7 [mRNA profiling]
KG1A 10nM DAC day3 [mRNA profiling]
MCF7 100nM DAC day10 [mRNA profiling]
MCF7 100nM DAC day3 [mRNA profiling]
MCF7 100nM DAC day1 [mRNA profiling]
Kasumi-1 300nM TSA 9 hours [mRNA profiling]
Kasumi-1 100nM ARA-C day3 [mRNA profiling]
Kasumi-1 500nM DAC day3 [mRNA profiling]
Kasumi-1 10nM DAC day3 (repeat) [mRNA profiling]
Kasumi-1 10nM DAC day14 [mRNA profiling]
Kasumi-1 10nM DAC day7 [mRNA profiling]
Kasumi-1 10nM DAC day3 [mRNA profiling]
Kasumi-1 leukemia cell line - 10nM DAC treated - day 3, rep2 [CH3'n profiling]
Kasumi-1 leukemia cell line - Untreated - rep2 [CH3'n profiling]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on